← FDA DRUG APPROVALS

FDA ANDA · ANDA076507

FLUCONAZOLE

Sponsor: TARO

APPLICATION
ANDA076507
TYPE
ANDA
ORIGINAL APPROVAL
2004-07-29
LATEST ACTION
2015-03-19
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

FLUCONAZOLEDiscontinued
FLUCONAZOLE 150MG · TABLET · ORAL
FLUCONAZOLEDiscontinued
FLUCONAZOLE 50MG · TABLET · ORAL
FLUCONAZOLEDiscontinued
FLUCONAZOLE 200MG · TABLET · ORAL
FLUCONAZOLEDiscontinued
FLUCONAZOLE 100MG · TABLET · ORAL

Approval history

2015-03-19Labeling · Supplement 6 · standardAP
2015-03-19Labeling · Supplement 7 · standardAP
2015-03-19Labeling · Supplement 5 · standardAP
2012-04-18Labeling · Supplement 4AP
2011-12-16Labeling · Supplement 3AP
2008-11-06Labeling · Supplement 2AP
2008-01-09Manufacturing (CMC) · Supplement 1AP
2004-07-29OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →